View the clinical evidence supporting the use of Vidium’s diagnostic tests.
Scientific Presentations
Tumor Genomic Analysis for Diagnostically Challenging Cancer Cases
Chon, E. et al
View
Genomic analysis across 50 canine cancer types reveals novel mutations and putative high clinical actionability
Sakthikumar, S. et al
Download PDF
Novel Genomic Prognostic Biomarkers for Canine Cancer Patients
Mutation Landscape and Clinical Actionability in Canine Melanoma
Development and Validation Procedures for Improving SearchLight DNA™
Warrier, M. et al
Design, Analytical Validation and Diagnostic Yield of a Novel Canine Cancer Gene Sequencing Panel.
Wong, S. et al
Publications
Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential.
Read Article
Novel genomic prognostic biomarkers for dogs with cancer
Genomic tumor analysis provides clinical guidance for the management of diagnostically challenging cancers in dogs
Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC